AA
Aarey Drugs & Pharmaceuticals
AAREYDRUGS.BO · BSE
₹105.30 +2.88% (+₹2.95)
1M +9.18%
Market Cap ₹2.97B
P/E Ratio 60.64x
Div. Yield -
ROE 3.53%
Analiza
Raport AI o biznesie, finansach, wycenie, sentymencie, wiadomościach i ryzykach - napisany w kilka minut.
Piotroski F-Score Moderate
4/9Valuation
30 /100
Expensive EV/EBITDA 27.48x
P/S 0.63x
P/B 1.97x
Growth
31 /100
Declining Rev. growth 4.38%
Book val. growth 10.33%
EPS growth 12.96%
Profitability
8 /100
Weak Net margin 1.03%
Op. margin 3.12%
FCF margin 0.00%
Quality
34 /100
Average ROE 3.53%
ROA 1.65%
Asset turnover 1.60x
Debt
57 /100
Moderate Current ratio 1.81x
Int. coverage 1.72x
Net debt/EBITDA 3.86x
Stability
53 /100
Moderate Rev. volatility 30.13%
EPS volatility 34.69%
Profitable years 4
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o AAREYDRUGS.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mihir Rajesh Ghatalia
Employees
132
Headquarters
Mumbai